Rosanna Peeling is currently Professor and Chair of Diagnostics Research at the London School of Hygiene and Tropical Medicine (LSHTM). She is also the Director of the International Diagnostics Centre (IDC). Trained as a medical microbiologist, Dr. Peeling had been Research Coordinator and Head of Diagnostics Research at the UNICEF/UNDP/World Bank/WHO Special Programme on Research and Training in Tropical Diseases (WHO/TDR) in Geneva, Switzerland, and the Chief of the Canadian National Laboratory for Sexually Transmitted Diseases before assuming her current position. 

David Heymann is a Professor of Infectious Disease Epidemiology at the London School of Hygiene and Tropical Medicine (LSHTM). He is also a Distinguished Fellow at the Centre on Universal Health at Chatham House, London. From 2009 to 2012 he was chairman of the UK Health Protection Agency, and from 2012 to March 2017 chairman of Public Health England.

Do Tuan Dat is a vaccine scientific, production, and business adviser in the Company for Vaccine and Biological Production (VABIOTECH) where he is responsible as a Senior Consultant. In this position, he consults all the R&D, quality management, production, and business activities in VABIOTECH. Before working at VABIOTECH, he studied at the Clinical Institute of Tropical and Infectious Diseases, Vietnam where he conducted research in the field of tropical and infectious diseases.

Amandeep Singh is a Vaccine Financing Specialist (Consultant) with ADB. Before ADB, he worked with Gavi as a Technical Advisor, Pandemic Preparedness and Response in the Policy Design team of the Office of the COVAX Facility. He also briefly consulted for UK FCDO's Center for Disaster Protection on the evolving global architecture of pandemic policies and financing.

Svilen Konov has a degree from the London School of Hygiene and Tropical Medicine. He has worked as a clinical trials methodologist on drug development, predominantly in the field of HIV and HCV as well as concomitant diseases, with large pharmaceutical companies and has developed research protocols and analysis plans. He has experience working with the EU regulator, the European Medicines Agency (EMA) on drug approval. In addition. Svilen worked with the World Health Organization on Emergency Medical Services (EMS).